JPRN-UMIN000000510已完成4 期
A genotype directed dose-finding study of Irinotecan (CPT-11) by groups of Uridine diphosphate glucuronosyltransferase 1A1 (UGT1A1) polymorphisms in patients with advanced metastatic colorectal cancer and gastric cancer. - UGT1A1 polymorphisms genotype-directed dose finding trial of Irinotecan(CPT-11) for gastrointestinal cancer.
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)History of serious drug allergy 2)Active concomitant malignancy 3)Prior extensively irradiation for abdominal or bowel bone marrow 4)Symptomatic brain metastasis 5)Systemic continual use of steroids 6)Active infection 7)Persistent diarrhea (watery stool) 8)Intestinal obstraction or paralytic ileus 9)Interstitial pneumonia or pulmonary fibrosis 10)Massive pleural, pericardial effusion or asites that required drainage 11)Need to treatment with atazanavir sulfate 12)Uncontrolled diabetes mellitus 13)Heart disease deemed to unacceptable by diagnosis of cardiogram within the previous 28 days before enrollment 14)Psychological disease deemed to unacceptable for inclusion to the study 15)Pregnant or lactating women, couple wishing pregnant or no mind of prevent pregnancy 16)Other concominant medical condition deemed to inadequate for inclusion to the study
研究者
相似试验
已完成
不适用
A genotype-directed dose finding study of irinotecan based on UGT1A1 polymorphisms in metastatic colorectal cancermetastatic colorectal cancerJPRN-UMIN000002166kobe University Hospital and Graduate School of Medicine18
已完成
1 期
Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal MalignanciesAcinar Cell Adenocarcinoma of the PancreasAdenocarcinoma of the GallbladderAdenocarcinoma of Unknown PrimaryAdult Primary Cholangiocellular CarcinomaAdvanced Adult Primary Liver CancerCholangiocarcinoma of the Extrahepatic Bile DuctCholangiocarcinoma of the GallbladderDiffuse Adenocarcinoma of the StomachDuct Cell Adenocarcinoma of the PancreasIntestinal Adenocarcinoma of the StomachLocalized Unresectable Adult Primary Liver CancerMetastatic Carcinoma of Unknown PrimaryMetastatic Extrahepatic Bile Duct CancerMixed Adenocarcinoma of the StomachMucinous Adenocarcinoma of the ColonMucinous Adenocarcinoma of the RectumNewly Diagnosed Carcinoma of Unknown PrimarySignet Ring Adenocarcinoma of the ColonSignet Ring Adenocarcinoma of the RectumStage III Pancreatic CancerStage IIIA Colon CancerStage IIIA Gallbladder CancerStage IIIA Gastric CancerStage IIIA Rectal CancerStage IIIB Colon CancerStage IIIB Gallbladder CancerStage IIIB Gastric CancerStage IIIB Rectal CancerStage IIIC Colon CancerStage IIIC Gastric CancerStage IIIC Rectal CancerStage IV Gastric CancerStage IV Pancreatic CancerStage IVA Colon CancerStage IVA Gallbladder CancerStage IVA Rectal CancerStage IVB Colon CancerStage IVB Gallbladder CancerStage IVB Rectal CancerUnresectable Extrahepatic Bile Duct CancerNCT01643499University of Chicago79
撤回
1 期
Irinotecan Hydrochloride With FOLFIRI and Cetuximab as First-Line Therapy in Treating Patients With RAS Wild-Type Colorectal CancerStage IVA Colorectal CancerStage IVB Colorectal CancerNCT02573220University of Chicago
已完成
1 期
A Genotype-guided Study of Irinotecan Administered in Combination With 5-fluorouracil/Leucovorin (FOLFIRI) and Bevacizumab in Advanced Colorectal Cancer PatientsMetastatic Colorectal CancerNCT01183494University of Chicago17
终止
1 期
Irinotecan for Previously Treated, Advanced, Non-Small Cell Lung CancerNon-small Cell Lung CancerNCT01607554New Mexico Cancer Care Alliance2